164 related articles for article (PubMed ID: 12703602)
1. Impact of health plan design and management on retirees' prescription drug use and spending, 2001.
Thomas CP; Wallack SS; Lee S; Ritter GA
Health Aff (Millwood); 2002; Suppl Web Exclusives():W408-19. PubMed ID: 12703602
[TBL] [Abstract][Full Text] [Related]
2. Employer drug benefit plans and spending on prescription drugs.
Joyce GF; Escarce JJ; Solomon MD; Goldman DP
JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
[TBL] [Abstract][Full Text] [Related]
3. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
Johnsrud M; Lawson KA; Shepherd MD
J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
[TBL] [Abstract][Full Text] [Related]
5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
6. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
7. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
[TBL] [Abstract][Full Text] [Related]
8. The effects of copayments and generic substitution on the use and costs of prescription drugs.
Smith DG
Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
[TBL] [Abstract][Full Text] [Related]
9. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
Carroll NV
J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
[TBL] [Abstract][Full Text] [Related]
10. Pharmacy benefit caps and the chronically ill.
Joyce GF; Goldman DP; Karaca-Mandic P; Zheng Y
Health Aff (Millwood); 2007; 26(5):1333-44. PubMed ID: 17848444
[TBL] [Abstract][Full Text] [Related]
11. Approaches to pharmacy benefit management and the impact of consumer cost sharing.
Olson BM
Clin Ther; 2003 Jan; 25(1):250-72. PubMed ID: 12637125
[TBL] [Abstract][Full Text] [Related]
12. Financial consequences of drug benefit plans.
Motheral B; Sheth J
JAMA; 2003 Jan 22-29; 289(4):423-4; author reply 424. PubMed ID: 12533119
[No Abstract] [Full Text] [Related]
13. Financial consequences of drug benefit plans.
Hsu J; Reed M
JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533118
[No Abstract] [Full Text] [Related]
14. Financial consequences of drug benefit plans.
Clark BE; Garis RI
JAMA; 2003 Jan 22-29; 289(4):423; author reply 424. PubMed ID: 12533117
[No Abstract] [Full Text] [Related]
15. Prescription drugs: issues of cost, coverage, and quality.
Copeland C
EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
[TBL] [Abstract][Full Text] [Related]
16. The effect of incentive-based formularies on prescription-drug utilization and spending.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Frank RG
N Engl J Med; 2003 Dec; 349(23):2224-32. PubMed ID: 14657430
[TBL] [Abstract][Full Text] [Related]
17. Pharmacy benefits: new concepts in plan design.
Goff VV
NHPF Issue Brief; 2002 Mar; (772):1-16. PubMed ID: 11915906
[TBL] [Abstract][Full Text] [Related]
18. Utilization effects of prescription drug benefits in an aging population.
Gianfrancesco FD; Baines AP; Richards D
Health Care Financ Rev; 1994; 15(3):113. PubMed ID: 10137793
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug copayments--fiduciary duty--plan discounts--disclosure. Alves v. Harvard Pilgrim Health Care, Inc.
Benefits Q; 2005; 21(2):61-3. PubMed ID: 15977753
[No Abstract] [Full Text] [Related]
20. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
